Latest FDA Stories
The U.S. Food and Drug Administration (FDA) has warned about the risks of dietary supplements containing live bacteria or yeast being taken by patients with compromised immune systems.
IGI Filed Eleven ANDAs in 2014, and IGI Now Has Twenty-Two Applications Pending at the FDA BUENA, N.J., Dec. 23, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
Accomplished physician Dr.
Patient recruitment in the WISE clinical study continues CAESAREA, Israel, December 22, 2014 /PRNewswire/ -- Allium Medical (TASE: ALMD), a medical device company
First-ever clearance of its kind in the US creates an important new option for patients and providers to perform home hemodialysis overnight while sleeping LAWRENCE, Mass., Dec.
FDA’s new proposed rules will make drug manufacturers revamp the way they register data on ClinicalTrials.gov.
- In Phase 3 clinical trials, VIEKIRA PAK cured 95-100 percent of hepatitis C patients, with less than 2 percent of patients experiencing virological failure NORTH CHICAGO, Ill., Dec.
Implants constructed from a novel porous resorbable biomaterial offer surgeons an attractive alternative to allograft WOBURN, Mass., Dec.
Increasingly FDA warning letters to GMP facilities cite violations in raw materials management.
ThermiAesthetics' Patients Show Significant Results with New, FDA-Cleared Device Southlake, TX (PRWEB) December 17, 2014 Radiofrequency is a staple
- The word or words serving to define another word or expression, as in a dictionary entry.